Ihuman Inc. income statement

In fiscal 2025, Ihuman Inc. reported revenue of $112m, down 12.4% on the year before, operating income of $9.3m (a 8.3% margin) and net income of $13.3m, or $0.25 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Ihuman Inc.: income statement, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	20	32	77	146	147	144	128	112
Cost of revenue	—	12	24	44	44	42	39	36
Gross profit	10	19	53	102	103	102	89	76
Research and development	8	25	29	64	47	36	34	29
Selling and marketing	3	8	14	31	23	28	31	25
General and administrative	2	27	17	15	16	15	14	13
Operating income	−3	−40	−6	−8	17	23	10	9
Income before tax	−2	−40	−5	−6	20	29	15	14
Income tax	0	0	0	−0	3	3	2	1
Net income	−3	−40	−5	−6	16	26	14	13
Diluted EPS	−$0.08	−$1.10	—	−$0.11	$0.31	$0.47	$0.25	$0.25
Diluted shares (average)	32m	36m	45m	53m	54m	55m	54m	54m
EBITDA	−3	−40	−6	−7	18	24	12	10

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: COE vs IH IH vs LGCY IH vs NRDY CHGG vs IH

More: Education Services stocks compared, Consumer Discretionary sector, rankings of US companies

Figures from Ihuman Inc.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Ihuman Inc.